Global VEGF Targeted Therapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Angiogenesis, the generation of new blood vessels, is an essential physiological process that can be dysregulated in various pathological conditions, including cancer. The vascular endothelial growth factor (VEGF) pathway is considered the most important and is a well-characterized contributor to angiogenesis. VEGF-A and other members of the VEGF family such as placental growth factor (PlGF) are upregulated in pathological conditions. VEGF-A, the first VEGF characterized, has served as a paradigm for the development of antiangiogenesis as a therapeutic strategy.
The global VEGF Targeted Therapy market size is projected to grow from US$ 891 million in 2024 to US$ 1303 million in 2030; it is expected to grow at a CAGR of 6.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “VEGF Targeted Therapy Industry Forecast” looks at past sales and reviews total world VEGF Targeted Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected VEGF Targeted Therapy sales for 2023 through 2029. With VEGF Targeted Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world VEGF Targeted Therapy industry.
This Insight Report provides a comprehensive analysis of the global VEGF Targeted Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on VEGF Targeted Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global VEGF Targeted Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for VEGF Targeted Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global VEGF Targeted Therapy.
United States market for VEGF Targeted Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for VEGF Targeted Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for VEGF Targeted Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key VEGF Targeted Therapy players cover Roche, Eli Lilly, Pfizer, Regeneron Pharmaceuticals, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of VEGF Targeted Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Angiogenesis, the generation of new blood vessels, is an essential physiological process that can be dysregulated in various pathological conditions, including cancer. The vascular endothelial growth factor (VEGF) pathway is considered the most important and is a well-characterized contributor to angiogenesis. VEGF-A and other members of the VEGF family such as placental growth factor (PlGF) are upregulated in pathological conditions. VEGF-A, the first VEGF characterized, has served as a paradigm for the development of antiangiogenesis as a therapeutic strategy.
The global VEGF Targeted Therapy market size is projected to grow from US$ 891 million in 2024 to US$ 1303 million in 2030; it is expected to grow at a CAGR of 6.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “VEGF Targeted Therapy Industry Forecast” looks at past sales and reviews total world VEGF Targeted Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected VEGF Targeted Therapy sales for 2023 through 2029. With VEGF Targeted Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world VEGF Targeted Therapy industry.
This Insight Report provides a comprehensive analysis of the global VEGF Targeted Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on VEGF Targeted Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global VEGF Targeted Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for VEGF Targeted Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global VEGF Targeted Therapy.
United States market for VEGF Targeted Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for VEGF Targeted Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for VEGF Targeted Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key VEGF Targeted Therapy players cover Roche, Eli Lilly, Pfizer, Regeneron Pharmaceuticals, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of VEGF Targeted Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Bevacizumab
- Ramucirumab
- Ranibizumab
- Aflibercept
- Conbercept
- Other
- Hospitals
- Clinics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bevacizumab
- Ramucirumab
- Ranibizumab
- Aflibercept
- Conbercept
- Other
- Hospitals
- Clinics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Eli Lilly
- Pfizer
- Regeneron Pharmaceuticals
- Novartis
- Alphamab Oncology
- Chengdu Kanghong Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global VEGF Targeted Therapy Market Size 2019-2030
2.1.2 VEGF Targeted Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for VEGF Targeted Therapy by Country/Region, 2019, 2023 & 2030
2.2 VEGF Targeted Therapy Segment by Type
2.2.1 Bevacizumab
2.2.2 Ramucirumab
2.2.3 Ranibizumab
2.2.4 Aflibercept
2.2.5 Conbercept
2.2.6 Other
2.3 VEGF Targeted Therapy Market Size by Type
2.3.1 VEGF Targeted Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global VEGF Targeted Therapy Market Size Market Share by Type (2019-2024)
2.4 VEGF Targeted Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 VEGF Targeted Therapy Market Size by Application
2.5.1 VEGF Targeted Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global VEGF Targeted Therapy Market Size Market Share by Application (2019-2024)
3 VEGF TARGETED THERAPY MARKET SIZE BY PLAYER
3.1 VEGF Targeted Therapy Market Size Market Share by Player
3.1.1 Global VEGF Targeted Therapy Revenue by Player (2019-2024)
3.1.2 Global VEGF Targeted Therapy Revenue Market Share by Player (2019-2024)
3.2 Global VEGF Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VEGF TARGETED THERAPY BY REGION
4.1 VEGF Targeted Therapy Market Size by Region (2019-2024)
4.2 Global VEGF Targeted Therapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas VEGF Targeted Therapy Market Size Growth (2019-2024)
4.4 APAC VEGF Targeted Therapy Market Size Growth (2019-2024)
4.5 Europe VEGF Targeted Therapy Market Size Growth (2019-2024)
4.6 Middle East & Africa VEGF Targeted Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas VEGF Targeted Therapy Market Size by Country (2019-2024)
5.2 Americas VEGF Targeted Therapy Market Size by Type (2019-2024)
5.3 Americas VEGF Targeted Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC VEGF Targeted Therapy Market Size by Region (2019-2024)
6.2 APAC VEGF Targeted Therapy Market Size by Type (2019-2024)
6.3 APAC VEGF Targeted Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe VEGF Targeted Therapy Market Size by Country (2019-2024)
7.2 Europe VEGF Targeted Therapy Market Size by Type (2019-2024)
7.3 Europe VEGF Targeted Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa VEGF Targeted Therapy by Region (2019-2024)
8.2 Middle East & Africa VEGF Targeted Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa VEGF Targeted Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VEGF TARGETED THERAPY MARKET FORECAST
10.1 Global VEGF Targeted Therapy Forecast by Region (2025-2030)
10.1.1 Global VEGF Targeted Therapy Forecast by Region (2025-2030)
10.1.2 Americas VEGF Targeted Therapy Forecast
10.1.3 APAC VEGF Targeted Therapy Forecast
10.1.4 Europe VEGF Targeted Therapy Forecast
10.1.5 Middle East & Africa VEGF Targeted Therapy Forecast
10.2 Americas VEGF Targeted Therapy Forecast by Country (2025-2030)
10.2.1 United States Market VEGF Targeted Therapy Forecast
10.2.2 Canada Market VEGF Targeted Therapy Forecast
10.2.3 Mexico Market VEGF Targeted Therapy Forecast
10.2.4 Brazil Market VEGF Targeted Therapy Forecast
10.3 APAC VEGF Targeted Therapy Forecast by Region (2025-2030)
10.3.1 China VEGF Targeted Therapy Market Forecast
10.3.2 Japan Market VEGF Targeted Therapy Forecast
10.3.3 Korea Market VEGF Targeted Therapy Forecast
10.3.4 Southeast Asia Market VEGF Targeted Therapy Forecast
10.3.5 India Market VEGF Targeted Therapy Forecast
10.3.6 Australia Market VEGF Targeted Therapy Forecast
10.4 Europe VEGF Targeted Therapy Forecast by Country (2025-2030)
10.4.1 Germany Market VEGF Targeted Therapy Forecast
10.4.2 France Market VEGF Targeted Therapy Forecast
10.4.3 UK Market VEGF Targeted Therapy Forecast
10.4.4 Italy Market VEGF Targeted Therapy Forecast
10.4.5 Russia Market VEGF Targeted Therapy Forecast
10.5 Middle East & Africa VEGF Targeted Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Market VEGF Targeted Therapy Forecast
10.5.2 South Africa Market VEGF Targeted Therapy Forecast
10.5.3 Israel Market VEGF Targeted Therapy Forecast
10.5.4 Turkey Market VEGF Targeted Therapy Forecast
10.6 Global VEGF Targeted Therapy Forecast by Type (2025-2030)
10.7 Global VEGF Targeted Therapy Forecast by Application (2025-2030)
10.7.1 GCC Countries Market VEGF Targeted Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche VEGF Targeted Therapy Product Offered
11.1.3 Roche VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly VEGF Targeted Therapy Product Offered
11.2.3 Eli Lilly VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Eli Lilly Main Business Overview
11.2.5 Eli Lilly Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer VEGF Targeted Therapy Product Offered
11.3.3 Pfizer VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Information
11.4.2 Regeneron Pharmaceuticals VEGF Targeted Therapy Product Offered
11.4.3 Regeneron Pharmaceuticals VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Regeneron Pharmaceuticals Main Business Overview
11.4.5 Regeneron Pharmaceuticals Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis VEGF Targeted Therapy Product Offered
11.5.3 Novartis VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Alphamab Oncology
11.6.1 Alphamab Oncology Company Information
11.6.2 Alphamab Oncology VEGF Targeted Therapy Product Offered
11.6.3 Alphamab Oncology VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Alphamab Oncology Main Business Overview
11.6.5 Alphamab Oncology Latest Developments
11.7 Chengdu Kanghong Pharmaceutical
11.7.1 Chengdu Kanghong Pharmaceutical Company Information
11.7.2 Chengdu Kanghong Pharmaceutical VEGF Targeted Therapy Product Offered
11.7.3 Chengdu Kanghong Pharmaceutical VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Chengdu Kanghong Pharmaceutical Main Business Overview
11.7.5 Chengdu Kanghong Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global VEGF Targeted Therapy Market Size 2019-2030
2.1.2 VEGF Targeted Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for VEGF Targeted Therapy by Country/Region, 2019, 2023 & 2030
2.2 VEGF Targeted Therapy Segment by Type
2.2.1 Bevacizumab
2.2.2 Ramucirumab
2.2.3 Ranibizumab
2.2.4 Aflibercept
2.2.5 Conbercept
2.2.6 Other
2.3 VEGF Targeted Therapy Market Size by Type
2.3.1 VEGF Targeted Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global VEGF Targeted Therapy Market Size Market Share by Type (2019-2024)
2.4 VEGF Targeted Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 VEGF Targeted Therapy Market Size by Application
2.5.1 VEGF Targeted Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global VEGF Targeted Therapy Market Size Market Share by Application (2019-2024)
3 VEGF TARGETED THERAPY MARKET SIZE BY PLAYER
3.1 VEGF Targeted Therapy Market Size Market Share by Player
3.1.1 Global VEGF Targeted Therapy Revenue by Player (2019-2024)
3.1.2 Global VEGF Targeted Therapy Revenue Market Share by Player (2019-2024)
3.2 Global VEGF Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VEGF TARGETED THERAPY BY REGION
4.1 VEGF Targeted Therapy Market Size by Region (2019-2024)
4.2 Global VEGF Targeted Therapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas VEGF Targeted Therapy Market Size Growth (2019-2024)
4.4 APAC VEGF Targeted Therapy Market Size Growth (2019-2024)
4.5 Europe VEGF Targeted Therapy Market Size Growth (2019-2024)
4.6 Middle East & Africa VEGF Targeted Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas VEGF Targeted Therapy Market Size by Country (2019-2024)
5.2 Americas VEGF Targeted Therapy Market Size by Type (2019-2024)
5.3 Americas VEGF Targeted Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC VEGF Targeted Therapy Market Size by Region (2019-2024)
6.2 APAC VEGF Targeted Therapy Market Size by Type (2019-2024)
6.3 APAC VEGF Targeted Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe VEGF Targeted Therapy Market Size by Country (2019-2024)
7.2 Europe VEGF Targeted Therapy Market Size by Type (2019-2024)
7.3 Europe VEGF Targeted Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa VEGF Targeted Therapy by Region (2019-2024)
8.2 Middle East & Africa VEGF Targeted Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa VEGF Targeted Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VEGF TARGETED THERAPY MARKET FORECAST
10.1 Global VEGF Targeted Therapy Forecast by Region (2025-2030)
10.1.1 Global VEGF Targeted Therapy Forecast by Region (2025-2030)
10.1.2 Americas VEGF Targeted Therapy Forecast
10.1.3 APAC VEGF Targeted Therapy Forecast
10.1.4 Europe VEGF Targeted Therapy Forecast
10.1.5 Middle East & Africa VEGF Targeted Therapy Forecast
10.2 Americas VEGF Targeted Therapy Forecast by Country (2025-2030)
10.2.1 United States Market VEGF Targeted Therapy Forecast
10.2.2 Canada Market VEGF Targeted Therapy Forecast
10.2.3 Mexico Market VEGF Targeted Therapy Forecast
10.2.4 Brazil Market VEGF Targeted Therapy Forecast
10.3 APAC VEGF Targeted Therapy Forecast by Region (2025-2030)
10.3.1 China VEGF Targeted Therapy Market Forecast
10.3.2 Japan Market VEGF Targeted Therapy Forecast
10.3.3 Korea Market VEGF Targeted Therapy Forecast
10.3.4 Southeast Asia Market VEGF Targeted Therapy Forecast
10.3.5 India Market VEGF Targeted Therapy Forecast
10.3.6 Australia Market VEGF Targeted Therapy Forecast
10.4 Europe VEGF Targeted Therapy Forecast by Country (2025-2030)
10.4.1 Germany Market VEGF Targeted Therapy Forecast
10.4.2 France Market VEGF Targeted Therapy Forecast
10.4.3 UK Market VEGF Targeted Therapy Forecast
10.4.4 Italy Market VEGF Targeted Therapy Forecast
10.4.5 Russia Market VEGF Targeted Therapy Forecast
10.5 Middle East & Africa VEGF Targeted Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Market VEGF Targeted Therapy Forecast
10.5.2 South Africa Market VEGF Targeted Therapy Forecast
10.5.3 Israel Market VEGF Targeted Therapy Forecast
10.5.4 Turkey Market VEGF Targeted Therapy Forecast
10.6 Global VEGF Targeted Therapy Forecast by Type (2025-2030)
10.7 Global VEGF Targeted Therapy Forecast by Application (2025-2030)
10.7.1 GCC Countries Market VEGF Targeted Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche VEGF Targeted Therapy Product Offered
11.1.3 Roche VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly VEGF Targeted Therapy Product Offered
11.2.3 Eli Lilly VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Eli Lilly Main Business Overview
11.2.5 Eli Lilly Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer VEGF Targeted Therapy Product Offered
11.3.3 Pfizer VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Information
11.4.2 Regeneron Pharmaceuticals VEGF Targeted Therapy Product Offered
11.4.3 Regeneron Pharmaceuticals VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Regeneron Pharmaceuticals Main Business Overview
11.4.5 Regeneron Pharmaceuticals Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis VEGF Targeted Therapy Product Offered
11.5.3 Novartis VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Alphamab Oncology
11.6.1 Alphamab Oncology Company Information
11.6.2 Alphamab Oncology VEGF Targeted Therapy Product Offered
11.6.3 Alphamab Oncology VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Alphamab Oncology Main Business Overview
11.6.5 Alphamab Oncology Latest Developments
11.7 Chengdu Kanghong Pharmaceutical
11.7.1 Chengdu Kanghong Pharmaceutical Company Information
11.7.2 Chengdu Kanghong Pharmaceutical VEGF Targeted Therapy Product Offered
11.7.3 Chengdu Kanghong Pharmaceutical VEGF Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Chengdu Kanghong Pharmaceutical Main Business Overview
11.7.5 Chengdu Kanghong Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. VEGF Targeted Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. VEGF Targeted Therapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Bevacizumab
Table 4. Major Players of Ramucirumab
Table 5. Major Players of Ranibizumab
Table 6. Major Players of Aflibercept
Table 7. Major Players of Conbercept
Table 8. Major Players of Other
Table 9. VEGF Targeted Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global VEGF Targeted Therapy Market Size by Type (2019-2024) & ($ millions)
Table 11. Global VEGF Targeted Therapy Market Size Market Share by Type (2019-2024)
Table 12. VEGF Targeted Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 13. Global VEGF Targeted Therapy Market Size by Application (2019-2024) & ($ millions)
Table 14. Global VEGF Targeted Therapy Market Size Market Share by Application (2019-2024)
Table 15. Global VEGF Targeted Therapy Revenue by Player (2019-2024) & ($ millions)
Table 16. Global VEGF Targeted Therapy Revenue Market Share by Player (2019-2024)
Table 17. VEGF Targeted Therapy Key Players Head office and Products Offered
Table 18. VEGF Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global VEGF Targeted Therapy Market Size by Region (2019-2024) & ($ millions)
Table 22. Global VEGF Targeted Therapy Market Size Market Share by Region (2019-2024)
Table 23. Global VEGF Targeted Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global VEGF Targeted Therapy Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas VEGF Targeted Therapy Market Size by Country (2019-2024) & ($ millions)
Table 26. Americas VEGF Targeted Therapy Market Size Market Share by Country (2019-2024)
Table 27. Americas VEGF Targeted Therapy Market Size by Type (2019-2024) & ($ millions)
Table 28. Americas VEGF Targeted Therapy Market Size Market Share by Type (2019-2024)
Table 29. Americas VEGF Targeted Therapy Market Size by Application (2019-2024) & ($ millions)
Table 30. Americas VEGF Targeted Therapy Market Size Market Share by Application (2019-2024)
Table 31. APAC VEGF Targeted Therapy Market Size by Region (2019-2024) & ($ millions)
Table 32. APAC VEGF Targeted Therapy Market Size Market Share by Region (2019-2024)
Table 33. APAC VEGF Targeted Therapy Market Size by Type (2019-2024) & ($ millions)
Table 34. APAC VEGF Targeted Therapy Market Size by Application (2019-2024) & ($ millions)
Table 35. Europe VEGF Targeted Therapy Market Size by Country (2019-2024) & ($ millions)
Table 36. Europe VEGF Targeted Therapy Market Size Market Share by Country (2019-2024)
Table 37. Europe VEGF Targeted Therapy Market Size by Type (2019-2024) & ($ millions)
Table 38. Europe VEGF Targeted Therapy Market Size by Application (2019-2024) & ($ millions)
Table 39. Middle East & Africa VEGF Targeted Therapy Market Size by Region (2019-2024) & ($ millions)
Table 40. Middle East & Africa VEGF Targeted Therapy Market Size by Type (2019-2024) & ($ millions)
Table 41. Middle East & Africa VEGF Targeted Therapy Market Size by Application (2019-2024) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of VEGF Targeted Therapy
Table 43. Key Market Challenges & Risks of VEGF Targeted Therapy
Table 44. Key Industry Trends of VEGF Targeted Therapy
Table 45. Global VEGF Targeted Therapy Market Size Forecast by Region (2025-2030) & ($ millions)
Table 46. Global VEGF Targeted Therapy Market Size Market Share Forecast by Region (2025-2030)
Table 47. Global VEGF Targeted Therapy Market Size Forecast by Type (2025-2030) & ($ millions)
Table 48. Global VEGF Targeted Therapy Market Size Forecast by Application (2025-2030) & ($ millions)
Table 49. Roche Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 50. Roche VEGF Targeted Therapy Product Offered
Table 51. Roche VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 52. Roche Main Business
Table 53. Roche Latest Developments
Table 54. Eli Lilly Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 55. Eli Lilly VEGF Targeted Therapy Product Offered
Table 56. Eli Lilly VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Eli Lilly Main Business
Table 58. Eli Lilly Latest Developments
Table 59. Pfizer Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 60. Pfizer VEGF Targeted Therapy Product Offered
Table 61. Pfizer VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Pfizer Main Business
Table 63. Pfizer Latest Developments
Table 64. Regeneron Pharmaceuticals Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 65. Regeneron Pharmaceuticals VEGF Targeted Therapy Product Offered
Table 66. Regeneron Pharmaceuticals VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Regeneron Pharmaceuticals Main Business
Table 68. Regeneron Pharmaceuticals Latest Developments
Table 69. Novartis Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 70. Novartis VEGF Targeted Therapy Product Offered
Table 71. Novartis VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Novartis Main Business
Table 73. Novartis Latest Developments
Table 74. Alphamab Oncology Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 75. Alphamab Oncology VEGF Targeted Therapy Product Offered
Table 76. Alphamab Oncology VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Alphamab Oncology Main Business
Table 78. Alphamab Oncology Latest Developments
Table 79. Chengdu Kanghong Pharmaceutical Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 80. Chengdu Kanghong Pharmaceutical VEGF Targeted Therapy Product Offered
Table 81. Chengdu Kanghong Pharmaceutical VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Chengdu Kanghong Pharmaceutical Main Business
Table 83. Chengdu Kanghong Pharmaceutical Latest Developments
Table 1. VEGF Targeted Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. VEGF Targeted Therapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Bevacizumab
Table 4. Major Players of Ramucirumab
Table 5. Major Players of Ranibizumab
Table 6. Major Players of Aflibercept
Table 7. Major Players of Conbercept
Table 8. Major Players of Other
Table 9. VEGF Targeted Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global VEGF Targeted Therapy Market Size by Type (2019-2024) & ($ millions)
Table 11. Global VEGF Targeted Therapy Market Size Market Share by Type (2019-2024)
Table 12. VEGF Targeted Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 13. Global VEGF Targeted Therapy Market Size by Application (2019-2024) & ($ millions)
Table 14. Global VEGF Targeted Therapy Market Size Market Share by Application (2019-2024)
Table 15. Global VEGF Targeted Therapy Revenue by Player (2019-2024) & ($ millions)
Table 16. Global VEGF Targeted Therapy Revenue Market Share by Player (2019-2024)
Table 17. VEGF Targeted Therapy Key Players Head office and Products Offered
Table 18. VEGF Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global VEGF Targeted Therapy Market Size by Region (2019-2024) & ($ millions)
Table 22. Global VEGF Targeted Therapy Market Size Market Share by Region (2019-2024)
Table 23. Global VEGF Targeted Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global VEGF Targeted Therapy Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas VEGF Targeted Therapy Market Size by Country (2019-2024) & ($ millions)
Table 26. Americas VEGF Targeted Therapy Market Size Market Share by Country (2019-2024)
Table 27. Americas VEGF Targeted Therapy Market Size by Type (2019-2024) & ($ millions)
Table 28. Americas VEGF Targeted Therapy Market Size Market Share by Type (2019-2024)
Table 29. Americas VEGF Targeted Therapy Market Size by Application (2019-2024) & ($ millions)
Table 30. Americas VEGF Targeted Therapy Market Size Market Share by Application (2019-2024)
Table 31. APAC VEGF Targeted Therapy Market Size by Region (2019-2024) & ($ millions)
Table 32. APAC VEGF Targeted Therapy Market Size Market Share by Region (2019-2024)
Table 33. APAC VEGF Targeted Therapy Market Size by Type (2019-2024) & ($ millions)
Table 34. APAC VEGF Targeted Therapy Market Size by Application (2019-2024) & ($ millions)
Table 35. Europe VEGF Targeted Therapy Market Size by Country (2019-2024) & ($ millions)
Table 36. Europe VEGF Targeted Therapy Market Size Market Share by Country (2019-2024)
Table 37. Europe VEGF Targeted Therapy Market Size by Type (2019-2024) & ($ millions)
Table 38. Europe VEGF Targeted Therapy Market Size by Application (2019-2024) & ($ millions)
Table 39. Middle East & Africa VEGF Targeted Therapy Market Size by Region (2019-2024) & ($ millions)
Table 40. Middle East & Africa VEGF Targeted Therapy Market Size by Type (2019-2024) & ($ millions)
Table 41. Middle East & Africa VEGF Targeted Therapy Market Size by Application (2019-2024) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of VEGF Targeted Therapy
Table 43. Key Market Challenges & Risks of VEGF Targeted Therapy
Table 44. Key Industry Trends of VEGF Targeted Therapy
Table 45. Global VEGF Targeted Therapy Market Size Forecast by Region (2025-2030) & ($ millions)
Table 46. Global VEGF Targeted Therapy Market Size Market Share Forecast by Region (2025-2030)
Table 47. Global VEGF Targeted Therapy Market Size Forecast by Type (2025-2030) & ($ millions)
Table 48. Global VEGF Targeted Therapy Market Size Forecast by Application (2025-2030) & ($ millions)
Table 49. Roche Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 50. Roche VEGF Targeted Therapy Product Offered
Table 51. Roche VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 52. Roche Main Business
Table 53. Roche Latest Developments
Table 54. Eli Lilly Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 55. Eli Lilly VEGF Targeted Therapy Product Offered
Table 56. Eli Lilly VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Eli Lilly Main Business
Table 58. Eli Lilly Latest Developments
Table 59. Pfizer Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 60. Pfizer VEGF Targeted Therapy Product Offered
Table 61. Pfizer VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Pfizer Main Business
Table 63. Pfizer Latest Developments
Table 64. Regeneron Pharmaceuticals Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 65. Regeneron Pharmaceuticals VEGF Targeted Therapy Product Offered
Table 66. Regeneron Pharmaceuticals VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Regeneron Pharmaceuticals Main Business
Table 68. Regeneron Pharmaceuticals Latest Developments
Table 69. Novartis Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 70. Novartis VEGF Targeted Therapy Product Offered
Table 71. Novartis VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Novartis Main Business
Table 73. Novartis Latest Developments
Table 74. Alphamab Oncology Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 75. Alphamab Oncology VEGF Targeted Therapy Product Offered
Table 76. Alphamab Oncology VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Alphamab Oncology Main Business
Table 78. Alphamab Oncology Latest Developments
Table 79. Chengdu Kanghong Pharmaceutical Details, Company Type, VEGF Targeted Therapy Area Served and Its Competitors
Table 80. Chengdu Kanghong Pharmaceutical VEGF Targeted Therapy Product Offered
Table 81. Chengdu Kanghong Pharmaceutical VEGF Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Chengdu Kanghong Pharmaceutical Main Business
Table 83. Chengdu Kanghong Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. VEGF Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global VEGF Targeted Therapy Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. VEGF Targeted Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. VEGF Targeted Therapy Sales Market Share by Country/Region (2023)
Figure 8. VEGF Targeted Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global VEGF Targeted Therapy Market Size Market Share by Type in 2023
Figure 10. VEGF Targeted Therapy in Hospitals
Figure 11. Global VEGF Targeted Therapy Market: Hospitals (2019-2024) & ($ millions)
Figure 12. VEGF Targeted Therapy in Clinics
Figure 13. Global VEGF Targeted Therapy Market: Clinics (2019-2024) & ($ millions)
Figure 14. Global VEGF Targeted Therapy Market Size Market Share by Application in 2023
Figure 15. Global VEGF Targeted Therapy Revenue Market Share by Player in 2023
Figure 16. Global VEGF Targeted Therapy Market Size Market Share by Region (2019-2024)
Figure 17. Americas VEGF Targeted Therapy Market Size 2019-2024 ($ millions)
Figure 18. APAC VEGF Targeted Therapy Market Size 2019-2024 ($ millions)
Figure 19. Europe VEGF Targeted Therapy Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa VEGF Targeted Therapy Market Size 2019-2024 ($ millions)
Figure 21. Americas VEGF Targeted Therapy Value Market Share by Country in 2023
Figure 22. United States VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC VEGF Targeted Therapy Market Size Market Share by Region in 2023
Figure 27. APAC VEGF Targeted Therapy Market Size Market Share by Type (2019-2024)
Figure 28. APAC VEGF Targeted Therapy Market Size Market Share by Application (2019-2024)
Figure 29. China VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 33. India VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe VEGF Targeted Therapy Market Size Market Share by Country in 2023
Figure 36. Europe VEGF Targeted Therapy Market Size Market Share by Type (2019-2024)
Figure 37. Europe VEGF Targeted Therapy Market Size Market Share by Application (2019-2024)
Figure 38. Germany VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 39. France VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 40. UK VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa VEGF Targeted Therapy Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa VEGF Targeted Therapy Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa VEGF Targeted Therapy Market Size Market Share by Application (2019-2024)
Figure 46. Egypt VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 52. APAC VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 53. Europe VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 55. United States VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 56. Canada VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 57. Mexico VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 58. Brazil VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 59. China VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 60. Japan VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 61. Korea VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 63. India VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 64. Australia VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 65. Germany VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 66. France VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 67. UK VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 68. Italy VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 69. Russia VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 70. Egypt VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 71. South Africa VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 72. Israel VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 73. Turkey VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 75. Global VEGF Targeted Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global VEGF Targeted Therapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. VEGF Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global VEGF Targeted Therapy Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. VEGF Targeted Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. VEGF Targeted Therapy Sales Market Share by Country/Region (2023)
Figure 8. VEGF Targeted Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global VEGF Targeted Therapy Market Size Market Share by Type in 2023
Figure 10. VEGF Targeted Therapy in Hospitals
Figure 11. Global VEGF Targeted Therapy Market: Hospitals (2019-2024) & ($ millions)
Figure 12. VEGF Targeted Therapy in Clinics
Figure 13. Global VEGF Targeted Therapy Market: Clinics (2019-2024) & ($ millions)
Figure 14. Global VEGF Targeted Therapy Market Size Market Share by Application in 2023
Figure 15. Global VEGF Targeted Therapy Revenue Market Share by Player in 2023
Figure 16. Global VEGF Targeted Therapy Market Size Market Share by Region (2019-2024)
Figure 17. Americas VEGF Targeted Therapy Market Size 2019-2024 ($ millions)
Figure 18. APAC VEGF Targeted Therapy Market Size 2019-2024 ($ millions)
Figure 19. Europe VEGF Targeted Therapy Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa VEGF Targeted Therapy Market Size 2019-2024 ($ millions)
Figure 21. Americas VEGF Targeted Therapy Value Market Share by Country in 2023
Figure 22. United States VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC VEGF Targeted Therapy Market Size Market Share by Region in 2023
Figure 27. APAC VEGF Targeted Therapy Market Size Market Share by Type (2019-2024)
Figure 28. APAC VEGF Targeted Therapy Market Size Market Share by Application (2019-2024)
Figure 29. China VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 33. India VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe VEGF Targeted Therapy Market Size Market Share by Country in 2023
Figure 36. Europe VEGF Targeted Therapy Market Size Market Share by Type (2019-2024)
Figure 37. Europe VEGF Targeted Therapy Market Size Market Share by Application (2019-2024)
Figure 38. Germany VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 39. France VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 40. UK VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa VEGF Targeted Therapy Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa VEGF Targeted Therapy Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa VEGF Targeted Therapy Market Size Market Share by Application (2019-2024)
Figure 46. Egypt VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries VEGF Targeted Therapy Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 52. APAC VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 53. Europe VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 55. United States VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 56. Canada VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 57. Mexico VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 58. Brazil VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 59. China VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 60. Japan VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 61. Korea VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 63. India VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 64. Australia VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 65. Germany VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 66. France VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 67. UK VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 68. Italy VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 69. Russia VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 70. Egypt VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 71. South Africa VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 72. Israel VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 73. Turkey VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries VEGF Targeted Therapy Market Size 2025-2030 ($ millions)
Figure 75. Global VEGF Targeted Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global VEGF Targeted Therapy Market Size Market Share Forecast by Application (2025-2030)
